Vitasora Health (ASX:VHL) Financial Strength: 0 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vitasora Health Financial Strength?

Vitasora Health has the Financial Strength Rank of 0.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Vitasora Health did not have earnings to cover the interest expense. Vitasora Health's debt to revenue ratio for the quarter that ended in Jun. 2026 was 0.00. As of today, Vitasora Health's Altman Z-Score is -6.45.


Vitasora Health  (ASX:VHL) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Vitasora Health has the Financial Strength Rank of 0.


Vitasora Health Financial Strength Related Terms


ASX:VHL vs VEEV, BTSG, TEM: Financial Strength Comparison

For the Health Information Services subindustry, Vitasora Health's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitasora Health Financial Strength vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vitasora Health's Financial Strength distribution charts can be found below:

* The bar in red indicates where Vitasora Health's Financial Strength falls into.



Vitasora Health Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Vitasora Health's Interest Expense for the months ended in Jun. 2026 was A$0.00 Mil. Its Operating Income for the months ended in Jun. 2026 was A$-5.49 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was A$0.00 Mil.

Vitasora Health's Interest Coverage for the quarter that ended in Jun. 2026 is

Vitasora Health had no long-term debt (1).

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Vitasora Health Ltd has enough cash to cover all of its debt. Its financial situation is stable.

2. Debt to revenue ratio. The lower, the better.

Vitasora Health's Debt to Revenue Ratio for the quarter that ended in Jun. 2026 is

Debt to Revenue Ratio=Total Debt (Q: Jun. 2026 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 3.955582
=0.00

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Vitasora Health has a Z-score of -6.45, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of -6.45 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vitasora Health Business Description

Other Exchanges VHLUF:USA
Address 432 Street Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Respiri Ltd is an Australian digital health company focused on remote respiratory monitoring and chronic disease management. Its principal product is wheezo, a wheeze-detection technology comprising a handheld sensor and mobile application that records and analyses breathing sounds, helping patients and clinicians monitor asthma and respiratory conditions. The company also develops related software and data services that support remote patient monitoring, care coordination, and clinical decision-making. Respiri targets healthcare providers, clinicians, payers, and patients, with commercial activity concentrated in Australia and the United States, where it has pursued partnerships with telehealth and chronic care organisations. Revenue is generated primarily through device and software sales, subscription and monitoring fees, and partnership arrangements with healthcare organisations. The company has evolved from earlier medical device development toward a software-enabled respiratory care platform.